- Home
- IONR vs ETON Comparison
IONR vs ETON Comparison
Compare IONR & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IONR
- ETON
- Stock Information
- Founded
- IONR 2001
- ETON 2017
- Country
- IONR Australia
- ETON United States
- Employees
- IONR N/A
- ETON N/A
- Industry
- IONR
- ETON Biotechnology: Pharmaceutical Preparations
- Sector
- IONR
- ETON Health Care
- Exchange
- IONR Nasdaq
- ETON Nasdaq
- Market Cap
- IONR 319.2M
- ETON 329.8M
- IPO Year
- IONR N/A
- ETON 2018
- Fundamental
- Price
- IONR $5.23
- ETON $14.41
- Analyst Decision
- IONR
- ETON Strong Buy
- Analyst Count
- IONR 0
- ETON 3
- Target Price
- IONR N/A
- ETON $18.67
- AVG Volume (30 Days)
- IONR 51.6K
- ETON 243.0K
- Earning Date
- IONR 01-01-0001
- ETON 03-13-2025
- Dividend Yield
- IONR N/A
- ETON N/A
- EPS Growth
- IONR N/A
- ETON N/A
- EPS
- IONR N/A
- ETON N/A
- Revenue
- IONR N/A
- ETON $34,677,000.00
- Revenue This Year
- IONR N/A
- ETON $22.25
- Revenue Next Year
- IONR N/A
- ETON $81.48
- P/E Ratio
- IONR N/A
- ETON N/A
- Revenue Growth
- IONR N/A
- ETON 5.64
- 52 Week Low
- IONR $2.90
- ETON $3.03
- 52 Week High
- IONR $9.35
- ETON $15.00
- Technical
- Relative Strength Index (RSI)
- IONR 66.61
- ETON 62.22
- Support Level
- IONR $4.05
- ETON $13.09
- Resistance Level
- IONR $4.58
- ETON $14.35
- Average True Range (ATR)
- IONR 0.41
- ETON 1.13
- MACD
- IONR 0.14
- ETON 0.08
- Stochastic Oscillator
- IONR 86.78
- ETON 82.60
About IONR ioneer Ltd
Ioneer Ltd is a mineral exploration company. The company's focus is on the Rhyolite Ridge Lithium-Boron Project located in Nevada, USA. Geographically, the group has a business presence in Australia and North America. The company's focus is to develop a U.S.-based source of lithium and boron that can be extracted in an environmentally and socially responsible manner, providing two materials that are essential to achieve a sustainable future for the planet.
About ETON Eton Pharmaceuticals Inc.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.